Advisors' clients are worried about both short- and long-term costs and whether Social Security and Medicare will be there when they retire, a new survey finds.
Sign-ups for Medicare’s GLP-1 coverage plan keep expanding, and Eli Lilly is dominating the market with 70% share, the company’s CEO David Ricks said.
Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.
Some health insurers push back on a Medicare proposal that would disrupt how doctors can bill for remotely monitoring patients' health.
STAT•Mario Aguilar9h ago
Eli Lilly and Novo Nordisk were already benefitting a great deal from the Trump administration's pilot program covering obesity drugs for seniors at a price of $245 a month. It…
STAT•Elaine Chen22 Sept
They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.
At best, older, laid-off workers will struggle to find health insurance that bridges the years before they qualify for Medicare at age 65.
The New York Times•Brian J. O’Connor20 Sept
Sen. Andy Kim (D-N.J.) on Thursday introduced legislation to phase out waiting periods for Social Security Disability Insurance (SSDI) and Medicare benefits. Kim’s bill, the Stop the Wait Act, would phase out the five-month waiting period for SSDI benefits over five years as well as eliminate the 24-month waiting period for Medicare disability benefits. The…
The Hill•Joseph Choi17 Sept
In this edition of STAT Health Tech: Zocdoc enables appointment scheduling from chatbots and health plan websites, and more.
STAT•Mario Aguilar17 Sept
The GOP bill directs MedPAC to study the topic of overpayments to Medicare Advantage plans in a manner that’s more favorable to insurers.
STAT•John Wilkerson16 Sept
Critics argue that the Inflation Reduction Act is increasing costs and reducing patient access to medications through price negotiations and Medicare Part D restructuring.
The Hill•Joel White and Hannah Anderson, opinion contributors16 Sept
The Trump administration is expanding Medicare’s new technology-based payment experiment to cover more chronic conditions, including COPD, substance use disorder and tobacco cessation.
Walmart will sell Medicare Advantage plans as part of a new partnership with a nonprofit health insurer.
A pilot program using artificial intelligence to approve care for Medicare beneficiaries has resulted in high levels of denials and delayed decisions and prompted warnings from a vendor about a lack of readiness, according to a lawsuit seeking information about the program.
A recently-launched Medicare experiment that pays for technology to help people manage chronic conditions is expanding.
STAT•Mario Aguilar15 Sept
The agency says the CMS and MA organizations aren’t doing enough to screen durable medical equipment providers, especially out-of-network companies that aren’t enrolled in Medicare.
In this edition of STAT Health Tech: The rushed launch of Medicare's AI prior-authorization pilot, policy hints from FDA, ONC officials, and more.
STAT•Mario Aguilar15 Sept
The rushed launch of a Medicare pilot to use AI for prior authorization led to delayed care in some instances, new documents reveal.
STAT•Brittany Trang15 Sept
Former Sen. Joe Manchin (W.Va.), a prominent centrist who left the Democratic Party at the end of his Senate career, has endorsed Sen. Susan Collins (R-Maine), praising her as the “soul of the Senate.” Manchin gave his nod to Collins over Troy Jackson, her progressive challenger who supports Medicare for All and dismantling Immigration and…
The Hill•Alexander Bolton14 Sept
Medicare spending on prostate cancer care rose sharply from 2012 to 2021, driven largely by increased spending on systemic therapies. Medscape Medical News
Medscape11 Sept